Joan Chypyha

Joan Chypyha

Director/Board Member at OVATION SCIENCE INC.

Net worth: 7 236 $ as of 2026-06-29

60 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Ms. Joan Chypyha is an Independent Director at Edesa Biotech, Inc., an Independent Director at Ovation Science, Inc. (Canada) and a President & Chief Executive Officer at Alto Pharmaceuticals Ltd. She is on the Board of Directors at Edesa Biotech, Inc. and Ovation Science, Inc. (Canada).
Ms. Chypyha was previously employed as a President by Canadian Dermatology Association, a President by Cipher Pharmaceuticals, Inc., a Chief Business Development Officer by Rhei Pharmaceuticals Ltd., and a VP-Corporate Development & General Manager by Barrier Therapeutics Canada, Inc. She also served on the board at Canadian Healthcare Licensing Association.
She received her undergraduate degree from the University of Toronto and an MBA from Queen's University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-10-19 200,000 ( 0.52% ) 7 000 $ 2026-06-29
2026-05-26 29 ( 0% ) 236 $ 2026-06-29

Joan Chypyha active positions

CompaniesPositionStart
OVATION SCIENCE INC. Director/Board Member 2018-02-01
EDESA BIOTECH, INC. Director/Board Member 2023-05-22
Chief Executive Officer 2007-12-31

Former positions of Joan Chypyha

CompaniesPositionEnd
President 2022-12-31
CIPHER PHARMACEUTICALS INC. President 2017-06-01
Rhei Pharmaceuticals Ltd.
Corporate Officer/Principal 2010-12-31
Barrier Therapeutics Canada, Inc.
Corporate Officer/Principal 2008-07-31
Canadian Healthcare Licensing Association
Director/Board Member -
See the detail of Joan Chypyha's experience

Training of Joan Chypyha

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Consumer Services

Canadian Healthcare Licensing Association

Health Technology

Consumer Non-Durables

Rhei Pharmaceuticals Ltd.

Barrier Therapeutics Canada, Inc.

Health Technology

Commercial Services